Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiomyocyte transplantation improves heart function

R K Li1, Z Q Jia, R D Weisel

  • 1Department of Clinical Biochemistry, Toronto Hospital-General Division, University of Toronto, Ontario, Canada.

The Annals of Thoracic Surgery
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery.

The Journal of thoracic and cardiovascular surgery·2005
Same author

In-silico screening of high production volume chemicals for mutagenicity using the MCASE QSAR expert system.

SAR and QSAR in environmental research·2003
Same author

Mid-term results of the Ross procedure.

Journal of cardiac surgery·2002
Same author

Angiogenesis: protein, gene, or cell therapy?

The heart surgery forum·2002
Same author

Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury.

The Annals of thoracic surgery·2002
Same author

Dilation of the sinotubular junction causes aortic insufficiency after aortic valve replacement with the Toronto SPV bioprosthesis.

The Journal of thoracic and cardiovascular surgery·2001
Same journal

Does prior percutaneous coronary revascularization negatively affect the outcomes of subsequent coronary artery bypass grafting?

The Annals of thoracic surgery·2026
Same journal

Lymph Node Dissection and Chylothorax - Balancing Oncologic Benefit Against Morbidity.

The Annals of thoracic surgery·2026
Same journal

Preserved Antegrade Pulmonary Blood Flow in Bidirectional Glenn: Outcomes and Considerations for Staged Palliation.

The Annals of thoracic surgery·2026
Same journal

Domo Arigato, Mr. Roboto.

The Annals of thoracic surgery·2026
Same journal

Impact of High SUVmax on Recurrence by Resection Strategy in Stage IA Adenocarcinoma ≤2 cm.

The Annals of thoracic surgery·2026
Same journal

Preoperative Treatment for Stage II NSCLC Requires Multidimensional Consideration.

The Annals of thoracic surgery·2026
See all related articles

Transplanting cultured cardiomyocytes into heart scar tissue limited scar expansion and improved heart function in rats. This cell therapy shows promise for preventing heart failure after myocardial injury.

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Biology
  • Tissue Engineering

Background:

  • Myocardial scar tissue resulting from heart injury can lead to heart failure.
  • Transplantation of cardiomyocytes offers a potential therapeutic strategy to repair damaged heart muscle.

Purpose of the Study:

  • To investigate the efficacy of transplanting cultured cardiomyocytes into myocardial scar tissue.
  • To assess the impact of this transplantation on scar expansion and cardiac function in a rat model.

Main Methods:

  • Cryoinjury was used to create myocardial scar tissue in rat left ventricles.
  • Cultured fetal rat cardiomyocytes were transplanted into the scar tissue of experimental groups.
  • Heart function was assessed using Langendorff preparations, and histological studies quantified scar size and cell integration.

Related Experiment Videos

Main Results:

  • Transplanted cardiomyocytes successfully integrated and formed cardiac tissue within the myocardial scar.
  • Scar expansion was significantly limited in the transplantation group compared to controls.
  • Cardiac function, including systolic and developed pressures, was improved in the transplantation group.

Conclusions:

  • Transplantation of cardiomyocytes into myocardial scars is a viable strategy for cardiac repair.
  • This approach effectively limits scar progression and enhances cardiac function post-injury.
  • The findings support the potential of cardiomyocyte transplantation for treating heart failure.